Molina Healthcare (NYSE:MOH) Shares Down 3.2% Following Analyst Downgrade

Molina Healthcare, Inc. (NYSE:MOH)’s stock price traded down 3.2% during mid-day trading on Friday after Barclays lowered their price target on the stock from $437.00 to $430.00. Barclays currently has an equal weight rating on the stock. Molina Healthcare traded as low as $336.87 and last traded at $341.18. 84,491 shares were traded during mid-day trading, a decline of 79% from the average session volume of 397,431 shares. The stock had previously closed at $352.30.

Other equities research analysts have also issued reports about the stock. Truist Financial lifted their price target on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a research note on Tuesday, February 20th. Stephens reissued an “equal weight” rating and set a $390.00 price target on shares of Molina Healthcare in a research report on Thursday. Bank of America lowered Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 price target on the stock. in a research report on Thursday, March 28th. Wells Fargo & Company cut their price objective on Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating for the company in a report on Monday, April 15th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a report on Thursday, April 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $396.09.

Insider Transactions at Molina Healthcare

In related news, Director Richard M. Schapiro sold 711 shares of the business’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the sale, the director now directly owns 12,207 shares in the company, valued at approximately $4,688,220.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CFO Mark Lowell Keim sold 15,000 shares of the business’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the transaction, the chief financial officer now owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard M. Schapiro sold 711 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the sale, the director now directly owns 12,207 shares in the company, valued at $4,688,220.42. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 16,711 shares of company stock worth $6,472,517. Company insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Annis Gardner Whiting Capital Advisors LLC bought a new position in shares of Molina Healthcare in the 3rd quarter valued at $30,000. McIlrath & Eck LLC bought a new position in Molina Healthcare in the fourth quarter valued at about $34,000. VisionPoint Advisory Group LLC boosted its stake in shares of Molina Healthcare by 105.6% during the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock valued at $36,000 after purchasing an additional 57 shares in the last quarter. Principal Securities Inc. acquired a new stake in shares of Molina Healthcare during the fourth quarter valued at about $42,000. Finally, Friedenthal Financial bought a new stake in shares of Molina Healthcare during the fourth quarter worth about $43,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Trading Down 2.9 %

The business’s fifty day moving average is $391.53 and its 200-day moving average is $371.87. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.54 and a current ratio of 1.54. The firm has a market cap of $20.05 billion, a P/E ratio of 18.57, a price-to-earnings-growth ratio of 1.03 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.46 by $0.27. The firm had revenue of $9.93 billion during the quarter, compared to analysts’ expectations of $9.45 billion. Molina Healthcare had a net margin of 2.99% and a return on equity of 30.99%. The company’s revenue was up 21.9% on a year-over-year basis. During the same period in the prior year, the company posted $5.81 EPS. Analysts predict that Molina Healthcare, Inc. will post 23.62 EPS for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.